Wei Wu
16Patents
7h-index
19Co-inventors
63Inventor score
Filing activity: Apr 17, 1998 → Jul 7, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5965583A | Substituted imidazoles useful in the treatment of inflammatory disease | Chemistry; Metallurgy | 26 | Expired |
| US8267553B2 | LED illuminant module for medical luminaires | Mechanical Engineering; Lighting; Heating | 25 | Active |
| US6040320A | 2-substituted imidazoles useful in the treatment of inflammatory diseases | Chemistry; Metallurgy | 13 | Expired |
| US6521655B1 | Substituted imidazoles useful in the treatment of inflammatory diseases | Chemistry; Metallurgy | 12 | Expired |
| US6214830A | Substituted imidazoles useful in the treatment of inflammatory diseases | Chemistry; Metallurgy | 10 | Expired |
| US5994563A | Arylmethylphosphonic acid derivatives useful in treating bone wasting diseases | Chemistry; Metallurgy | 7 | Expired |
| US9638406B1 | Energy-saving device of surgical light | Emerging Cross-Sectional Technologies | 7 | Active |
| US10295164B2 | Illumination control device of surgical light | Emerging Cross-Sectional Technologies | 5 | Active |
| US9920922B2 | Automatic light intensity compensating device of surgical light | Emerging Cross-Sectional Technologies | 2 | Active |
| US9763299B1 | Surgical light with luminous intensity fine adjustment function | Physics | 1 | Active |
| US8901836B2 | Dimming controlling circuit for LED | Emerging Cross-Sectional Technologies | 0 | Active |
| US9081011B2 | Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (R-spondins) and/or Wnt | Physics | 0 | Active |
| US8921056B2 | Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (R-Spondins) and/or Wnt | Physics | 0 | Active |
| US11757003B2 | Bonding wafer structure and method of manufacturing the same | Electricity | 0 | Active |
| US9366242B2 | Bidirectional output mixed hydraulic power system | Emerging Cross-Sectional Technologies | 0 | Active |
| US8951745B2 | Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (R-Spondins) and/or Wnt | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.